Immunome, Inc.
IMNM
$27.20
$0.782.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -73.13M | -53.84M | -69.90M | -57.46M | -43.40M |
| Total Depreciation and Amortization | 1.16M | 753.00K | 776.00K | 733.00K | 720.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.35M | 8.03M | 17.95M | 5.88M | 5.03M |
| Change in Net Operating Assets | 1.92M | -13.58M | 3.22M | 10.33M | -11.76M |
| Cash from Operations | -61.69M | -58.64M | -47.95M | -40.51M | -49.40M |
| Capital Expenditure | -2.18M | -3.00M | -4.00M | -1.12M | -905.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -302.18M | -9.01M | 0.00 | 125.00M | -63.27M |
| Cash from Investing | -304.35M | -12.02M | -4.00M | 123.88M | -64.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.06M | 229.00K | 460.58M | 46.31M | 215.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -364.00K | -27.78M | -919.00K | -270.00K |
| Cash from Financing | 1.06M | -135.00K | 432.80M | 45.39M | -55.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -364.99M | -70.79M | 380.84M | 128.76M | -113.63M |